Company Number: SC676426

Analysis Date: 2025-07-19 12:46 UTC

Financial Health Assessment for HERE'STHEPLAN LIMITED (as at 31 March 2024)

---

1. Financial Health Score: B

Explanation:
HERE'STHEPLAN LIMITED shows solid financial footing with positive net assets and healthy working capital. However, there are signs of tightening liquidity and a drop in net assets compared to the prior year that warrant attention. Overall, the company is financially stable but could improve liquidity and cash flow management to sustain growth and resilience.

---

2. Key Vital Signs

Metric	Value (2024)	Interpretation
Net Assets (Shareholder Funds)	£688,431	Positive net worth indicates financial stability and an equity buffer for creditors. Slight decline from £735,648 in 2023 suggests some erosion of reserves.
Current Assets	£1,101,464	Healthy level of short-term resources available to cover liabilities.
Current Liabilities	£552,282	Obligations due within one year; increased sharply from prior year (£182,059), potentially indicating increased short-term debt or payables.
Net Current Assets (Working Capital)	£549,182	Positive and substantial, indicating good short-term liquidity to meet immediate obligations. However, decreased from £665,106 in 2023, a symptom of growing short-term pressures.
Cash at Bank and in Hand	£6,244	Very low cash balance, a critical symptom of liquidity strain despite high current assets. Cash is the "blood" of business health; low cash can limit operational agility.
Debtors	£273,785	Moderate level of amounts owed by customers; effective credit control is vital. Reduced from prior year’s £807,469, which may indicate improved collections or lower sales on credit.
Stock (Inventory)	£821,435	Large stock holding, significantly increased from £592,687 last year; while it supports sales, excessive inventory can tie up cash and risk obsolescence.
Fixed Assets	£139,249	Investment in long-term assets, including intangible assets (R&D systems). Indicates investment in company infrastructure and intellectual property.
Employee Count	29 (2024)	Growing workforce (+3 from 2023) implies business expansion but also increased overheads.

---

3. Diagnosis: Financial Health Overview

• Balance Sheet Strength: The company maintains a positive net asset position (£688k), reflecting an overall solvent position and providing a cushion against financial shocks. The equity base is stable but has slightly declined, indicating some use of reserves or accumulated losses.

• Liquidity Condition: Despite strong current assets and positive working capital, the very low cash balance (£6k) is a concerning symptom—akin to a patient with a strong heart but low blood pressure. The company holds significant stock, which while an asset, is less liquid than cash and debtors. The jump in current liabilities to £552k from £182k last year suggests increased short-term obligations which could pressure cash flow.

• Receivables and Inventory: Debtors reduced markedly, which is generally positive (better collection), but the high stock levels could indicate overstocking or slower sales cycles, potentially tying up cash unnecessarily.

• Fixed Asset Investment: The company’s increase in fixed assets, especially intangible assets (R&D systems), suggests investment in future capabilities, a positive sign of strategic growth and innovation.

• Profit & Loss Transparency: The company opted not to file detailed profit and loss accounts, limiting visibility on profitability trends. However, the slight net asset decrease could hint at marginal losses or reinvestment.

• Operational Scale: Headcount growth suggests increased activity and potential revenue expansion but also increased fixed costs.

---

4. Prognosis: Future Financial Outlook

• The company is currently in a stable but watchful state. The symptoms of tightening liquidity (low cash) and rising short-term liabilities could lead to operational stress if not managed carefully.

• Maintaining or improving cash flow through better inventory management and timely collection of receivables will be critical to avoid liquidity crises.

• Continued investment in intangible assets and workforce growth suggests potential for future revenue gains, but these must be balanced against cash constraints.

• If the company can convert its stock effectively into sales and cash, and manage liabilities prudently, it is well-positioned to sustain healthy growth.

• Failure to address liquidity concerns could lead to financial distress symptoms, such as inability to meet short-term obligations, which would deteriorate financial health.

---

5. Recommendations: Steps to Improve Financial Wellness

1. Enhance Cash Flow Management:

   • Prioritize collection of outstanding debts to boost cash reserves.
   • Evaluate credit terms with customers to accelerate cash inflows.
   • Explore short-term financing options as a buffer against cash shortfalls.

2. Optimize Inventory Levels:

   • Conduct a thorough review of stock turnover to identify slow-moving or obsolete inventory.
   • Implement just-in-time inventory practices where possible to reduce cash tie-up.

3. Manage Current Liabilities:

   • Negotiate extended payment terms with suppliers to ease short-term pressure.
   • Monitor and manage creditor payments to maintain good relationships while preserving cash.

4. Increase Financial Reporting Transparency:

   • Consider filing full accounts including profit and loss statements to provide stakeholders with better insight into profitability and operational efficiency.

5. Strategic Investment Review:

   • Assess the return on investment for recent intangible and tangible asset additions to ensure they contribute positively to revenue growth.

6. Regular Financial Health Checkups:

   • Establish monthly financial reviews focusing on cash flow forecasts, working capital, and key ratios to detect symptoms early and respond proactively.

---

Medical Analogy Summary:
HERE'STHEPLAN LIMITED shows a "healthy heart" with solid equity and net assets, but "low blood pressure" in terms of cash on hand signals potential liquidity stress. The company’s "immune system" (working capital) is robust but has weakened slightly. With attentive "treatment" focusing on cash flow and inventory control, the company can maintain and improve its financial health and avoid symptoms of distress.

---